DECISION RX

Welcome to the Brand page for “DECISION RX”, which is offered here for Assays for research purposes; diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents to monitor toxicity of drugs; diagnostic reagents for clinical or medical laboratory use; laboratory chemicals, an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use;diagnostic services in the field of cancer treatment and diagnosis;rx;medical and scientific research services in the field of cancer treatment and diagnosis;.

Its status is currently believed to be active. Its class is unavailable. “DECISION RX” is believed to be currently owned by “Nuclea Biotechnologies, LLC”.

Owner:
NUCLEA BIOTECHNOLOGIES, LLC
Owner Details
Description:
Assays for research purposes; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents to monitor toxicity of drugs; Diagnostic reagents for clinical or medical laboratory use; Laboratory chemicals, an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use;diagnostic services in the field of cancer treatment and diagnosis;RX;Medical and scientific research services in the field of cancer treatment and diagnosis;
Categories: ASSAYS RESEARCH PURPOSES